Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Therapy in Myocardial Infarction (COMBAT-MI)
2015-001000-58Phase 3Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Jun 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial of exenatide in myocardial infarction (MI) (2 arms), sponsored by Vall d'Hebron Research Institute. Primary endpoint: Infarct size by cardiac MRI. Started Jun 2015; status: completed.
02
Drugs
exenatide
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2015-001000-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001000-58.